Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H33NO3 |
| Molecular Weight | 335.4809 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1
InChI
InChIKey=IQADUMSPOQKAAO-UHFFFAOYSA-N
InChI=1S/C20H33NO3/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4/h9-13H,5-8,14-17H2,1-4H3
DescriptionSources: http://www.drugbank.ca/drugs/DB04822Curator's Comment: Description was created based on several sources, including http://www.fda.gov.ph/consumers-corner/registered-drugs-2/337707-DR-X1387
Sources: http://www.drugbank.ca/drugs/DB04822
Curator's Comment: Description was created based on several sources, including http://www.fda.gov.ph/consumers-corner/registered-drugs-2/337707-DR-X1387
Oxeladin citrate is a cough suppressant, is a highly potent and effective drug used to treat all types of cough of various etiologies. Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity. Oxeladine is a component of antitussive drug, Altussan, approved in Philippines.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QR05DB09
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
R05DB09
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C170272
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
CHEMBL1500276
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
4619
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
C005461
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
Oxeladin
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
SNC1080T5Y
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
468-61-1
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
m8299
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | Merck Index | ||
|
2018
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
DB04822
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
207-412-1
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
SUB09513MIG
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
677
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
100000083056
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
32626
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID0048343
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
